# Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury

> **NCT01329757** · PHASE3 · COMPLETED · sponsor: **Hospital Nacional de Parapléjicos de Toledo** · enrollment: 76 (actual)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** GH
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01329757
- **Lead sponsor:** Hospital Nacional de Parapléjicos de Toledo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2022-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01329757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01329757, "Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01329757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*